SOPHiA GENETICS (SOPH) Revenue (2020 - 2026)

Over the twelve months ended Jun 30, 2026, SOPHiA GENETICS's Revenue came in at $86.17 million, up 23.6% year-over-year; for the year ended Dec 31, 2025, it came in at $77.27 million, up 18.6% from the prior year.

• Revenue has increased for six consecutive years, with a five-year compound annual growth rate of 22.2% (years ended Dec 2020 to Dec 2025).
• By year, Revenue came in at $65.17 million in the year ended Dec 31, 2024 (+4.5%), $62.37 million in the year ended Dec 31, 2023 (+31.1%), $47.56 million in the year ended Dec 31, 2022 (+17.6%) and $40.45 million in the year ended Dec 31, 2021 (+42.4%).
• The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Revenue in data going back to the quarter ended Jun 30, 2020.
• Year over year, Revenue has now increased in each of the last seven quarters, with growth averaging 15.5% over the last eight quarters.
• The high point for year-over-year Revenue in five years was the quarter ended Sep 30, 2021 (growth of 44.5%); the low point was the quarter ended Sep 30, 2024 (a decline of 2.8%).
• Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $21.69 million (quarter ended Mar 31, 2026), $21.71 million (quarter ended Dec 31, 2025) and $19.46 million (quarter ended Sep 30, 2025).